Tower Research Capital (TRC)’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-912
| Closed | -$5.17K | – | 5627 |
|
|
2025
Q1 | $5.17K | Sell |
912
-97
| -10% | -$550 | ﹤0.01% | 4149 |
|
|
2024
Q4 | $5.06K | Buy |
1,009
+205
| +25% | +$1.03K | ﹤0.01% | 4357 |
|
|
2024
Q3 | $5.38K | Sell |
804
-1,151
| -59% | -$7.7K | ﹤0.01% | 4285 |
|
|
2024
Q2 | $18.7K | Buy |
1,955
+1,507
| +336% | +$14.4K | ﹤0.01% | 3790 |
|
|
2024
Q1 | $6.03K | Buy |
448
+143
| +47% | +$1.93K | ﹤0.01% | 4448 |
|
|
2023
Q4 | $4.13K | Sell |
305
-70
| -19% | -$948 | ﹤0.01% | 4989 |
|
|
2023
Q3 | $8.98K | Buy |
375
+46
| +14% | +$1.1K | ﹤0.01% | 4283 |
|
|
2023
Q2 | $10.3K | Sell |
329
-56
| -15% | -$1.76K | ﹤0.01% | 4110 |
|
|
2023
Q1 | $9K | Sell |
385
-92
| -19% | -$2.15K | ﹤0.01% | 4556 |
|
|
2022
Q4 | $9K | Buy |
477
+132
| +38% | +$2.49K | ﹤0.01% | 4290 |
|
|
2022
Q3 | $7K | Buy |
345
+68
| +25% | +$1.38K | ﹤0.01% | 4942 |
|
|
2022
Q2 | $6K | Buy |
277
+102
| +58% | +$2.21K | ﹤0.01% | 4967 |
|
|
2022
Q1 | $5K | Buy |
175
+132
| +307% | +$3.77K | ﹤0.01% | 5123 |
|
|
2021
Q4 | $2K | Hold |
43
| – | – | ﹤0.01% | 5687 |
|
|
2021
Q3 | $1K | Sell |
43
-56
| -57% | -$1.3K | ﹤0.01% | 5552 |
|
|
2021
Q2 | $5K | Buy |
99
+56
| +130% | +$2.83K | ﹤0.01% | 4746 |
|
|
2021
Q1 | $2K | Sell |
43
-479
| -92% | -$22.3K | ﹤0.01% | 5063 |
|
|
2020
Q4 | $28K | Buy |
522
+479
| +1,114% | +$25.7K | ﹤0.01% | 3633 |
|
|
2020
Q3 | $1K | Sell |
43
-174
| -80% | -$4.05K | ﹤0.01% | 4743 |
|
|
2020
Q2 | $7K | Buy |
217
+174
| +405% | +$5.61K | ﹤0.01% | 4177 |
|
|
2020
Q1 | $1K | Hold |
43
| – | – | ﹤0.01% | 2865 |
|
|
2019
Q4 | $3K | Buy |
43
+12
| +39% | +$837 | ﹤0.01% | 2981 |
|
|
2019
Q3 | $2K | Buy |
31
+19
| +158% | +$1.23K | ﹤0.01% | 3753 |
|
|
2019
Q2 | $2K | Sell |
12
-164
| -93% | -$27.3K | ﹤0.01% | 3332 |
|
|
2019
Q1 | $26K | Buy |
176
+123
| +232% | +$18.2K | ﹤0.01% | 2133 |
|
|
2018
Q4 | $6K | Buy |
+53
| New | +$6K | ﹤0.01% | 2824 |
|